Washington HB1034 aims to ensure nonopioid drugs are not disadvantaged in pain management coverage.
Washington HB1034 prohibits health plans from disadvantaging nonopioid drugs for pain treatment starting January 1, 2026. This includes not designating nonopioid drugs as nonpreferred if opioids are preferred and avoiding more restrictive prescription drug practices for nonopioids than opioids. The Department of Health must also create an educational pamphlet on nonopioid alternatives for pain treatment by January 1, 2026.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
Analyze for Free
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.